Trevi Therapeutics, Inc.
TRVI
$6.47
$0.121.89%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 29.71% | -26.30% | -26.19% | -34.55% | -31.15% |
Total Receivables | 9.69% | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -74.07% | -70.88% | -39.46% | 142.12% | 355.47% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -28.72% | -63.48% | -60.12% | -55.25% | -64.15% |
Total Current Assets | 24.99% | -28.33% | -27.30% | -32.78% | -28.60% |
|
|||||
Total Current Assets | 24.99% | -28.33% | -27.30% | -32.78% | -28.60% |
Net Property, Plant & Equipment | -21.17% | -20.05% | -16.98% | -16.69% | 703.61% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -18.18% | -13.80% | 301.47% | 38.22% | 44.88% |
Total Assets | 24.05% | -28.14% | -26.90% | -32.40% | -27.32% |
|
|||||
Total Accounts Payable | 88.72% | 28.50% | 11.76% | 6.51% | -36.68% |
Total Accrued Expenses | 83.61% | 98.95% | 60.03% | -18.19% | 5.43% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -6.86% | 1.71% | 11.55% | -95.84% | -95.64% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 80.44% | 76.36% | 43.32% | -60.03% | -56.54% |
|
|||||
Total Current Liabilities | 80.44% | 76.36% | 43.32% | -60.03% | -56.54% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -27.62% | -26.68% | -25.90% | -25.39% | 51,500.00% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 64.18% | 58.11% | 29.34% | -56.99% | -55.93% |
|
|||||
Common Stock & APIC | 20.18% | 4.15% | 3.04% | 1.30% | 1.28% |
Retained Earnings | -20.04% | -19.16% | -17.34% | -15.51% | -13.84% |
Treasury Stock & Other | 310.34% | 164.06% | 66.13% | 23.86% | 76.23% |
Total Common Equity | 20.71% | -34.19% | -30.40% | -28.90% | -23.18% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 20.71% | -34.19% | -30.40% | -28.90% | -23.18% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 20.71% | -34.19% | -30.40% | -28.90% | -23.18% |
|